The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-[3-Cyano-4-(4-tert-butylbenzyloxy)]phenylpyrimidine-4-ol ID: ALA4857117
PubChem CID: 164610317
Max Phase: Preclinical
Molecular Formula: C22H21N3O2
Molecular Weight: 359.43
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)(C)c1ccc(COc2ccc(-c3nccc(O)n3)cc2C#N)cc1
Standard InChI: InChI=1S/C22H21N3O2/c1-22(2,3)18-7-4-15(5-8-18)14-27-19-9-6-16(12-17(19)13-23)21-24-11-10-20(26)25-21/h4-12H,14H2,1-3H3,(H,24,25,26)
Standard InChI Key: QMBFRCJBEHLILL-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
17.9974 -22.1714 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9963 -22.9910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7043 -23.3999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4140 -22.9905 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4112 -22.1678 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7025 -21.7626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1143 -21.7579 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8238 -22.1655 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.5295 -21.7549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5269 -20.9369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8127 -20.5311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1099 -20.9440 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.2883 -23.3990 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.7071 -24.2176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7069 -25.0348 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.8067 -19.7139 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.5809 -22.9899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8728 -23.3979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1662 -22.9865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4587 -23.3939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4576 -24.2120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1699 -24.6210 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8746 -24.2113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7501 -24.6209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0422 -24.2127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7505 -25.4381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0379 -25.0234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
5 7 1 0
2 13 1 0
14 15 3 0
3 14 1 0
11 16 1 0
13 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
21 24 1 0
24 25 1 0
24 26 1 0
24 27 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 359.43Molecular Weight (Monoisotopic): 359.1634AlogP: 4.60#Rotatable Bonds: 4Polar Surface Area: 79.03Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.55CX Basic pKa: 0.94CX LogP: 5.72CX LogD: 5.72Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.74Np Likeness Score: -1.36
References 1. Sun M, Zhao J, Mao Q, Yan C, Zhang B, Yang Y, Dai X, Gao J, Lin F, Duan Y, Zhang T, Wang S.. (2021) Synthesis and biological evaluation of 2-(4-alkoxy-3-cyano)phenylpyrimidine derivatives with 4-amino or 4-hydroxy as a pharmacophore element binding with xanthine oxidase active site., 38 [PMID:33838610 ] [10.1016/j.bmc.2021.116117 ]